{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:11:59Z","timestamp":1793236319937,"version":"4.5.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.neuropharm.2020.108052","type":"journal-article","created":{"date-parts":[[2020,3,15]],"date-time":"2020-03-15T10:21:28Z","timestamp":1584267688000},"page":"108052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"special_numbering":"C","title":["Amygdala, neuropeptides, and chronic pain-related affective behaviors"],"prefix":"10.1016","volume":"170","author":[{"given":"Volker","family":"Neugebauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Mazzitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Cragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"Navratilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108052_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1744-8069-6-60","article-title":"Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity\/transmission in the amygdala in a mouse inflammatory pain model","volume":"6","author":"Adedoyin","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0361-9230(01)00493-2","article-title":"Microinjection of arginine vasopressin into the central nucleus of amygdala suppressed nociceptive jaw opening reflex in freely moving rats","volume":"55","author":"Ahn","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.108052_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yfrne.2014.07.001","article-title":"Species, sex and individual differences in the vasotocin\/vasopressin system: relationship to neurochemical signaling in the social behavior neural network","volume":"36","author":"Albers","year":"2015","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108052_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.08.010","article-title":"Contribution of amygdala CRF neurons to chronic pain","volume":"298","author":"Andreoli","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0304-3940(94)90631-9","article-title":"On the effect of ageing on the distribution of vasoactive intestinal polypeptide and calcitonin gene-related peptide in the rat brain","volume":"171","author":"Andreose","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib7","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1523\/JNEUROSCI.0483-18.2018","article-title":"Central amygdala circuits mediate hyperalgesia in alcohol-dependent rats","volume":"38","author":"Avegno","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuropharm.2013.09.025","article-title":"Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA)","volume":"77","author":"Baiamonte","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib9","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/j.pain.0000000000000240","article-title":"Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations","volume":"156","author":"Bannister","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib10","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1097\/j.pain.0000000000001040","article-title":"Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain","volume":"158","author":"Bannister","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1042\/BST20120251","article-title":"The activation of the CGRP receptor","volume":"41","author":"Barwell","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2020.108052_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/frne.1995.1013","article-title":"Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides","volume":"16","author":"Behan","year":"1995","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0079-6123(08)61868-3","article-title":"Involvement of the spino-parabrachio -amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain","volume":"107","author":"Bernard","year":"1996","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1152\/jn.1992.68.2.551","article-title":"Nucleus centralis of the amygdala and the globus pallidus ventralis: electrophysiological evidence for an involvement in pain processes","volume":"68","author":"Bernard","year":"1992","journal-title":"J.Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib15","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1523\/JNEUROSCI.0204-15.2015","article-title":"Mu-opioid receptor-mediated inhibition of intercalated neurons and effect on synaptic transmission to the central amygdala","volume":"35","author":"Blaesse","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.23-02-00700.2003","article-title":"Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse Hippocampus: role in neuronal excitability and associative learning","volume":"23","author":"Blank","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jpain.2010.05.004","article-title":"Corticotropin-releasing factor in the rat amygdala differentially influences sensory-discriminative and emotional-like pain response in peripheral neuropathy","volume":"11","author":"Bourbia","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008528","article-title":"CRF1-R activation of the dynorphin\/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior","volume":"4","author":"Bruchas","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108052_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/syn.21953","article-title":"Distribution of type I corticotropin-releasing factor (CRF1) receptors on GABAergic neurons within the basolateral amygdala","volume":"71","author":"Calakos","year":"2017","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.108052_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1744-8069-4-24","article-title":"Hemispheric lateralization of a molecular signal for pain modulation in the amygdala","volume":"4","author":"Carrasquillo","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fendo.2017.00356","article-title":"The oxytocin-vasopressin pathway in the context of love and fear","volume":"8","author":"Carter","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib23","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1523\/JNEUROSCI.15-10-06340.1995","article-title":"Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression","volume":"15","author":"Chalmers","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/npp.2012.3","article-title":"Prevention of stress-impaired fear extinction through neuropeptide s action in the lateral amygdala","volume":"37","author":"Chauveau","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8","article-title":"Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus","volume":"420","author":"Chen","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/cne.21025","article-title":"Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity","volume":"497","author":"Chieng","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib27","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/cne.22606","article-title":"Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry","volume":"519","author":"Clark","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/JPR.S188619","article-title":"Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action","volume":"12","author":"Coffeen","year":"2019","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib29","first-page":"56","article-title":"Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats","volume":"20","author":"Cohen","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2020.108052_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2018.08.013","article-title":"The left central nucleus of the amygdala contributes to mechanical allodynia and hyperalgesia following right-sided peripheral nerve injury","volume":"684","author":"Cooper","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.aap8586","article-title":"An amygdalar neural ensemble that encodes the unpleasantness of pain","volume":"363","author":"Corder","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108052_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916676491","article-title":"Differential contributions of vasopressin V1A and oxytocin receptors in the amygdala to pain-related behaviors in rats","volume":"12","author":"Cragg","year":"2016","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2003.09.050","article-title":"Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats","volume":"995","author":"Cui","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cne.21495","article-title":"Topography of thalamic and parabrachial calcitonin gene-related peptide (CGRP) immunoreactive neurons projecting to subnuclei of the amygdala and extended amygdala","volume":"505","author":"D'Hanis","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fnins.2013.00156","article-title":"Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis","volume":"7","author":"Dabrowska","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-6147(02)01946-6","article-title":"The CRF peptide family and their receptors: yet more partners discovered","volume":"23","author":"Dautzenberg","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1096-9861(19991011)413:1<113::AID-CNE8>3.0.CO;2-B","article-title":"Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta","volume":"413","author":"Day","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib40","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-019-09183-0","article-title":"Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.108052_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1874467210666170302104053","article-title":"The CRF family of neuropeptides and their receptors - mediators of the central stress response","volume":"11","author":"Dedic","year":"2018","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41593-018-0151-z","article-title":"Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety","volume":"21","author":"Dedic","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/13892037113149990057","article-title":"Role of CGRP-receptor component protein (RCP) in CLR\/RAMP function","volume":"14","author":"Dickerson","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cne.20618","article-title":"Calcitonin gene-related peptide-containing pathways in the rat forebrain","volume":"489","author":"Dobolyi","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopsych.2010.05.039","article-title":"Assessment of the neuropeptide S system in anxiety disorders","volume":"68","author":"Donner","year":"2010","journal-title":"Biol.Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108052_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2015.04.003","article-title":"Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior","volume":"40","author":"Dumais","year":"2016","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib47","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuron.2014.04.042","article-title":"Amygdala microcircuits controlling learned fear","volume":"82","author":"Duvarci","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.npp.1300607","article-title":"Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids","volume":"30","author":"Ebner","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.0953-816x.2001.01869.x","article-title":"Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats","volume":"15","author":"Ebner","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.yhbeh.2011.12.014","article-title":"The contributions of oxytocin and vasopressin pathway genes to human behavior","volume":"61","author":"Ebstein","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2020.108052_bib51","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1523\/JNEUROSCI.4496-03.2004","article-title":"Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current","volume":"24","author":"Faber","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature21047","article-title":"A competitive inhibitory circuit for selection of active and passive fear responses","volume":"542","author":"Fadok","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108052_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.conb.2018.02.009","article-title":"New perspectives on central amygdala function","volume":"49","author":"Fadok","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neulet.2010.03.028","article-title":"Intra-amygdala injections of neuropeptide S block fear-potentiated startle","volume":"474","author":"Fendt","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.104.074633","article-title":"Effect of the {\u00b5} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala","volume":"312","author":"Finnegan","year":"2005","journal-title":"J Pharmacol Exp.Ther."},{"key":"10.1016\/j.neuropharm.2020.108052_bib56","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1152\/jn.01004.2005","article-title":"{\u00b5} opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through kv1.1\/1.2 channels","volume":"95","author":"Finnegan","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0006-8993(94)91120-7","article-title":"Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges","volume":"648","author":"Fox","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2007.11.063","article-title":"The vasopressin system--from antidiuresis to psychopathology","volume":"583","author":"Frank","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib59","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00213-014-3436-2","article-title":"Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys","volume":"231","author":"Freeman","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib60","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1523\/JNEUROSCI.0227-08.2008","article-title":"Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior","volume":"28","author":"Fu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yhbeh.2015.04.001","article-title":"GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis","volume":"76","author":"Gafford","year":"2015","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2020.108052_bib62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1113\/eph8702357","article-title":"Pain pathways and parabrachial circuits in the rat","volume":"87","author":"Gauriau","year":"2002","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuropharm.2013.10.005","article-title":"Kappa opioid receptor activation decreases inhibitory transmission and antagonizes alcohol effects in rat central amygdala","volume":"77","author":"Gilpin","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbagen.2004.12.001","article-title":"Nine new human Rhodopsin family G-protein coupled receptors: identification, sequence characterisation and evolutionary relationship","volume":"1722","author":"Gloriam","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108052_bib65","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/j.1460-9568.2012.08235.x","article-title":"Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation","volume":"36","author":"Goncalves","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(84)90386-X","article-title":"Distribution of pro-opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala","volume":"306","author":"Gray","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib67","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cne.902620304","article-title":"Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat","volume":"262","author":"Gray","year":"1987","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0196-9781(92)90074-D","article-title":"Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat","volume":"13","author":"Gray","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108052_bib69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2982.2005.00648.x","article-title":"Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats","volume":"17","author":"Greenwood-Van Meerveld","year":"2005","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.neuropharm.2020.108052_bib70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/med.20180","article-title":"Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor","volume":"30","author":"Guerrini","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0304-3940(89)90301-7","article-title":"Effects of age on binding sites for calcitonin gene-related peptide in the rat central nervous system","volume":"102","author":"Guidobono","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-6-10","article-title":"Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats","volume":"6","author":"Han","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib73","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1523\/JNEUROSCI.4112-05.2005","article-title":"Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior","volume":"25","author":"Han","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib74","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neulet.2003.12.027","article-title":"Synaptic plasticity in the amygdala in a visceral pain model in rats","volume":"361","author":"Han","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2015.05.057","article-title":"Elucidating an affective pain circuit that creates a threat memory","volume":"162","author":"Han","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.108052_bib76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0361-9230(94)90079-5","article-title":"Corticotropin releasing factor neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus","volume":"33","author":"Harrigan","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.108052_bib77","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature09553","article-title":"Genetic dissection of an amygdala microcircuit that gates conditioned fear","volume":"468","author":"Haubensak","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108052_bib78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.108.00372","article-title":"International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor","volume":"60","author":"Hay","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib79","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1037\/0735-7044.106.3.518","article-title":"The amygdala is essential for the expression of conditional hypoalgesia","volume":"106","author":"Helmstetter","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-8993(93)91669-J","article-title":"Lesions of the amygdala block conditional hypoalgesia on the tail flick test","volume":"612","author":"Helmstetter","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib81","series-title":"Central Adenosine A1 and A2A Receptors Mediate the Antinociceptive Effects of Neuropeptide S in the Mouse Formalin Test","first-page":"8","author":"Holanda","year":"2015"},{"key":"10.1016\/j.neuropharm.2020.108052_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172557","article-title":"Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test","volume":"859","author":"Holanda","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(90)90484-Q","article-title":"Simultaneous localization of calcitonin gene-related peptide and neurotensin in rat central amygdaloid nucleus","volume":"113","author":"Honkaniemi","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.1105636","article-title":"Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala","volume":"308","author":"Huber","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108052_bib85","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0367-16.2017","article-title":"Intrinsic circuits in the lateral central amygdala","volume":"4","author":"Hunt","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2020.108052_bib86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pain.2006.09.003","article-title":"NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain","volume":"127","author":"Ikeda","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib87","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(86)90423-3","article-title":"Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains","volume":"374","author":"Inagaki","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib88","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/npp.2011.317","article-title":"Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons","volume":"37","author":"Ionescu","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib89","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/npp.2016.44","article-title":"Traumatic stress promotes hyperalgesia via corticotropin-releasing factor-1 receptor (CRFR1) signaling in central amygdala","volume":"41","author":"Itoga","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib90","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib91","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.neuroscience.2008.12.061","article-title":"Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis","volume":"159","author":"Jaferi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature14188","article-title":"From circuits to behaviour in the amygdala","volume":"517","author":"Janak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108052_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-8069-9-2","article-title":"Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses","volume":"9","author":"Ji","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-8069-3-13","article-title":"Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala","volume":"3","author":"Ji","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib95","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1152\/jn.00135.2007","article-title":"Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala","volume":"97","author":"Ji","year":"2007","journal-title":"J.Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib96","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1152\/jn.01148.2007","article-title":"Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors","volume":"99","author":"Ji","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib97","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1152\/jn.00166.2009","article-title":"Hemispheric lateralization of pain processing by amygdala neurons","volume":"1102","author":"Ji","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ejn.12432","article-title":"CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model","volume":"39","author":"Ji","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184380","article-title":"Contribution of corticotropin-releasing factor receptor 1 (CRF1) to serotonin receptor 5-HT2CR function in amygdala neurons in a neuropathic pain model","volume":"20","author":"Ji","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib100","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1523\/JNEUROSCI.0225-10.2010","article-title":"Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation","volume":"30","author":"Ji","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib101","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1523\/JNEUROSCI.2468-16.2016","article-title":"5-HT2C receptor knockdown in the amygdala inhibits neuropathic-pain-related plasticity and behaviors","volume":"37","author":"Ji","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib102","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/mp.2012.136","article-title":"Gestational environment programs adult depression-like behavior through methylation of the calcitonin gene-related peptide gene","volume":"18","author":"Jiao","year":"2013","journal-title":"Mol.Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108052_bib103","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1038\/tp.2015.16","article-title":"Knockdown of corticotropin-releasing factor in the central amygdala reverses persistent viscerosomatic hyperalgesia","volume":"5","author":"Johnson","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108052_bib104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2017.01.034","article-title":"Oxytocin and vasopressin neural networks: implications for social behavioral diversity and translational neuroscience","volume":"76","author":"Johnson","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuron.2008.07.002","article-title":"Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala","volume":"59","author":"Jungling","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib106","doi-asserted-by":"crossref","first-page":"19567","DOI":"10.1073\/pnas.1004100107","article-title":"Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system","volume":"107","author":"Kallupi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2020.108052_bib107","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/jpet.112.202903","article-title":"kappa-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites","volume":"346","author":"Kang-Park","year":"2013","journal-title":"J.Pharmacol.Exp.Ther."},{"key":"10.1016\/j.neuropharm.2020.108052_bib108","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.115.225870","article-title":"Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala","volume":"355","author":"Kang-Park","year":"2015","journal-title":"J.Pharmacol.Exp.Ther."},{"key":"10.1016\/j.neuropharm.2020.108052_bib109","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-981-13-1756-9_14","article-title":"Pain-associated neural plasticity in the parabrachial to central amygdala circuit : pain changes the brain, and the brain changes the pain","volume":"1099","author":"Kato","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.neuron.2017.02.034","article-title":"Basolateral to central amygdala neural circuits for appetitive behaviors","volume":"93","author":"Kim","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib111","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1523\/JNEUROSCI.4047-15.2016","article-title":"Rescue of impaired mGluR5-driven endocannabinoid signaling restores prefrontal cortical output to inhibit pain in arthritic rats","volume":"36","author":"Kiritoshi","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib112","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/acschemneuro.8b00022","article-title":"Pathway-specific alterations of cortico-amygdala transmission in an arthritis pain model","volume":"9","author":"Kiritoshi","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib113","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neuron.2011.11.030","article-title":"Evoked axonal oxytocin release in the central amygdala attenuates fear response","volume":"73","author":"Knobloch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib114","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2009.03.038","article-title":"Brain stress systems in the amygdala and addiction","volume":"1293","author":"Koob","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib116","first-page":"63","article-title":"Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor","volume":"11","author":"Koob","year":"2010","journal-title":"Curr.Opin.Investig.Drugs"},{"key":"10.1016\/j.neuropharm.2020.108052_bib117","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/npp.2011.213","article-title":"Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view","volume":"37","author":"Koob","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2005.12.034","article-title":"Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain","volume":"1072","author":"Korosi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib119","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","article-title":"Vasopressin V1a and V1b receptors: from molecules to physiological systems","volume":"92","author":"Koshimizu","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1254\/jphs.08R18FM","article-title":"New topics in vasopressin receptors and approach to novel drugs: vasopressin and pain perception","volume":"109","author":"Koshimizu","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib121","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00429-013-0674-8","article-title":"Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry","volume":"220","author":"Kravets","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108052_bib122","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/cne.902730203","article-title":"Distribution of calcitonin gene-related peptide immunoreactivity in relation to the rat central somatosensory projection","volume":"273","author":"Kruger","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib123","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","article-title":"Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication","volume":"25","author":"Landgraf","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(99)00193-1","article-title":"The role of corticotropin-releasing factor in pain and analgesia","volume":"84","author":"Lariviere","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib125","doi-asserted-by":"crossref","first-page":"R868","DOI":"10.1016\/j.cub.2007.08.005","article-title":"The amygdala","volume":"17","author":"LeDoux","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroscience.2010.10.020","article-title":"Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system","volume":"172","author":"Leonard","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib127","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1113\/JP276935","article-title":"The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain","volume":"596","author":"Li","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2009.03.013","article-title":"Neuropeptide S produces antinociceptive effects at the supraspinal level in mice","volume":"156","author":"Li","year":"2009","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108052_bib129","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2011.08.016","article-title":"Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects","volume":"62","author":"Lukas","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib131","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0306-4522(03)00159-3","article-title":"Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems","volume":"120","author":"Ma","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib132","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3959(95)00027-P","article-title":"The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test","volume":"63","author":"Manning","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib133","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib134","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cne.21464","article-title":"Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division","volume":"504","author":"Marchant","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1113\/expphysiol.1997.sp004022","article-title":"Identification of projections from the central nucleus of the amygdala to the paraventricular nucleus of the hypothalamus which are immunoreactive for corticotrophin-releasing hormone in the rat","volume":"82","author":"Marcilhac","year":"1997","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib136","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fmed.2015.00019","article-title":"A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin","volume":"2","author":"Mavani","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.neuropharm.2020.108052_bib138","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuron.2015.07.002","article-title":"CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety","volume":"87","author":"McCall","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib139","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0010-18.2018","article-title":"Quantified coexpression analysis of central amygdala subpopulations","volume":"5","author":"McCullough","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2020.108052_bib140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3959(01)00440-7","article-title":"Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity","volume":"96","author":"McGaraughty","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib141","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0306-4522(02)00105-7","article-title":"Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal","volume":"112","author":"McNally","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib142","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-10-32","article-title":"Nasal application of neuropeptide S inhibits arthritis pain-related behaviors through an action in the amygdala","volume":"10","author":"Medina","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib143","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/aja.1001650404","article-title":"Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain","volume":"165","author":"Merchenthaler","year":"1982","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.neuropharm.2020.108052_bib144","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cne.902410304","article-title":"Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus","volume":"241","author":"Moga","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cns.12490","article-title":"Stress and the microbiota-gut-brain Axis in visceral pain: relevance to irritable bowel syndrome","volume":"22","author":"Moloney","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2020.108052_bib146","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0306-4522(98)00732-5","article-title":"Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain","volume":"92","author":"Morin","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib147","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1097\/j.pain.0000000000000265","article-title":"Altered pain modulation in patients with persistent postendodontic pain","volume":"156","author":"Nasri-Heir","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib148","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/j.pain.0000000000001167","article-title":"Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain","volume":"159","author":"Nation","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib149","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/j.pain.0000000000001458","article-title":"Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain","volume":"160","author":"Navratilova","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib150","series-title":"Selective Modulation of Tonic Aversive Qualities of Neuropathic Pain by Morphine in the Central Nucleus of the Amygdala Requires Endogenous Opioid Signaling in the Anterior Cingulate Cortex. Pain","author":"Navratilova","year":"2019"},{"key":"10.1016\/j.neuropharm.2020.108052_bib151","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nn.3811","article-title":"Reward and motivation in pain and pain relief","volume":"17","author":"Navratilova","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib152","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-662-46450-2_13","article-title":"Amygdala pain mechanisms","volume":"227","author":"Neugebauer","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib153","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/jn.00264.2001","article-title":"Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input","volume":"87","author":"Neugebauer","year":"2002","journal-title":"J.Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib154","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1152\/jn.00799.2002","article-title":"Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain","volume":"89","author":"Neugebauer","year":"2003","journal-title":"J.Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1523\/JNEUROSCI.23-01-00052.2003","article-title":"Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5","volume":"23","author":"Neugebauer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib156","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2020.108052_bib157","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib158","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1126\/science.1092550","article-title":"Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors","volume":"303","author":"Nie","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108052_bib159","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SPC.0000000000000126","article-title":"Conditioned pain modulation","volume":"9","author":"Nir","year":"2015","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.neuropharm.2020.108052_bib160","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917709201","article-title":"Potentiation of NMDA receptor-mediated synaptic transmission at the parabrachial-central amygdala synapses by CGRP in mice","volume":"13","author":"Okutsu","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib161","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0361-9230(00)00420-2","article-title":"Role of PAG in the antinociception evoked from the medial or central amygdala in rats","volume":"54","author":"Oliveira","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.108052_bib162","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-328X(98)00052-7","article-title":"Distribution of novel CGRP1 receptor and adrenomedullin receptor mRNAs in the rat central nervous system","volume":"57","author":"Oliver","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib163","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuroscience.2007.07.003","article-title":"Noradrenergic agonist administration into the central nucleus of the amygdala increases the tail-flick latency in lightly anesthetized rats","volume":"148","author":"Ortiz","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib164","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","article-title":"Descending pain modulation and chronification of pain","volume":"8","author":"Ossipov","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.neuropharm.2020.108052_bib165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tins.2018.03.007","article-title":"The parabrachial nucleus: CGRP neurons function as a general alarm","volume":"41","author":"Palmiter","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib166","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002826-199619050-00009","article-title":"Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain","volume":"19","author":"Pande","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib167","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2009.06.001","article-title":"Neuropeptide S: a transmitter system in the brain regulating fear and anxiety","volume":"58","author":"Pape","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib168","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/physrev.00037.2009","article-title":"Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear","volume":"90","author":"Pape","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-8993(96)00880-3","article-title":"Opioid antagonists in the periaqueductal gray inhibit morphine and \u03b2-endorphin analgesia elicited from the amygdala of rats","volume":"741","author":"Pavlovic","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib170","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.peptides.2010.08.015","article-title":"Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor","volume":"31","author":"Peng","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108052_bib171","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.peptides.2010.06.027","article-title":"Effects of central neuropeptide S in the mouse formalin test","volume":"31","author":"Peng","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108052_bib172","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1523\/JNEUROSCI.4166-13.2014","article-title":"Fear conditioning potentiates synaptic transmission onto long-range projection neurons in the lateral subdivision of central amygdala","volume":"34","author":"Penzo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib173","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.pain.2013.04.012","article-title":"Facilitated temporal processing of pain and defective supraspinal control of pain in cluster headache","volume":"154","author":"Perrotta","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib174","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/j.pain.0000000000001553","article-title":"Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain","volume":"160","author":"Phelps","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib175","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41380-018-0089-2","article-title":"Stress peptides sensitize fear circuitry to promote passive coping","volume":"25","author":"Pliota","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108052_bib176","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/7854_2017_14","article-title":"Oxytocin signaling in pain: cellular, circuit, system, and behavioral levels","volume":"35","author":"Poisbeau","year":"2018","journal-title":"Curr.Top.Behav.Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108052_bib177","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnins.2015.00487","article-title":"A transgenic rat for investigating the anatomy and function of corticotrophin releasing factor circuits","volume":"9","author":"Pomrenze","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib178","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1523\/JNEUROSCI.2143-18.2018","article-title":"A corticotropin releasing factor network in the extended amygdala for anxiety","volume":"39","author":"Pomrenze","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib179","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cne.21587","article-title":"Enkephalin co-expression with classic neurotransmitters in the amygdaloid complex of the rat","volume":"506","author":"Poulin","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/j.pain.0000000000000759","article-title":"Amygdala-mediated mechanisms regulate visceral hypersensitivity in adult females following early life stress: importance of the glucocorticoid receptor and corticotropin-releasing factor","volume":"158","author":"Prusator","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib181","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.01.036","article-title":"Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats","volume":"117","author":"Przybysz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib182","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1111\/j.1460-9568.2012.08265.x","article-title":"Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze","volume":"36","author":"Pulga","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib183","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yfrne.2013.10.001","article-title":"Corticotropin releasing factor in neuroplasticity","volume":"35","author":"Regev","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib184","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/400_2007_051","article-title":"Neuropeptide S: anatomy, pharmacology, genetics and physiological functions","volume":"46","author":"Reinscheid","year":"2008","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.neuropharm.2020.108052_bib185","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/jn.00874.2012","article-title":"Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors","volume":"110","author":"Ren","year":"2013","journal-title":"J.Neurophysiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib186","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1744-8069-6-93","article-title":"Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1","volume":"6","author":"Ren","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","article-title":"Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression","volume":"2","author":"Reul","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib188","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.expneurol.2011.04.001","article-title":"Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers","volume":"230","author":"Reyes","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib189","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00429-016-1261-6","article-title":"Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety","volume":"222","author":"Reyes","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108052_bib190","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2009.11.007","article-title":"Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence","volume":"67","author":"Roberto","year":"2010","journal-title":"Biol.Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108052_bib191","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-8993(78)91147-2","article-title":"Influence of intra-amygdaloid opiate injections on shock thresholds, tail-flick latencies and open field behaviour in rats","volume":"153","author":"Rodgers","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib192","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpain.2011.05.016","article-title":"Experimental neuropathy increases limbic forebrain CRF","volume":"16","author":"Rouwette","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib193","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0306-4522(02)00455-4","article-title":"Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses","volume":"115","author":"Royer","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib194","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1530-0277.2009.01070.x","article-title":"Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats","volume":"34","author":"Ruggeri","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib195","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.neuropharm.2011.12.036","article-title":"Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor","volume":"62","author":"Ruzza","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib196","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/j.pain.0000000000000830","article-title":"Divergent functions of the left and right central amygdala in visceral nociception","volume":"158","author":"Sadler","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib197","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(86)91332-6","article-title":"Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex","volume":"382","author":"Sakanaka","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib198","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/dneu.20358","article-title":"Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons","volume":"67","author":"Salio","year":"2007","journal-title":"Dev.Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib199","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuron.2016.11.034","article-title":"A central amygdala CRF circuit facilitates learning about weak threats","volume":"93","author":"Sanford","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.psyneuen.2018.03.016","article-title":"Regulation of anxiety-like behavior and Crhr1 expression in the basolateral amygdala by LMO3","volume":"92","author":"Savarese","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib201","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/164_2017_86","article-title":"Corticotropin-releasing factor (CRF) neurocircuitry and neuropharmacology in alcohol drinking","volume":"248","author":"Schreiber","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cne.902700310","article-title":"Neurons containing calcitonin gene-related peptide in the parabrachial nucleus project to the central nucleus of the amygdala","volume":"270","author":"Schwaber","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0196-9781(01)00387-4","article-title":"Mouse models of altered CRH-binding protein expression","volume":"22","author":"Seasholtz","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108052_bib204","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00250584","article-title":"Light and electron microscopic studies of calcitonin gene-related peptide-like immunoreactive terminals in the central nucleus of the amygdala and the bed nucleus","volume":"77","author":"Shimada","year":"1989","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0304-3940(92)90526-D","article-title":"Synaptic contacts between CGRP-immunoreactive terminals and enkephalin-immunoreactive neurons in the central amygdaloid nucleus of the rat","volume":"134","author":"Shimada","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib206","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/ejn.13662","article-title":"Essential role of endogenous calcitonin gene-related peptide in pain-associated plasticity in the central amygdala","volume":"46","author":"Shinohara","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib207","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hbm.22199","article-title":"The human amygdala and pain: evidence from neuroimaging","volume":"35","author":"Simons","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2020.108052_bib208","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0196-9781(85)90178-0","article-title":"Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system","volume":"6","author":"Skofitsch","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108052_bib209","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1523\/JNEUROSCI.4764-13.2015","article-title":"Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activity","volume":"35","author":"Slattery","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib210","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1523\/JNEUROSCI.2980-11.2012","article-title":"Stress-induced activation of the dynorphin\/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference","volume":"32","author":"Smith","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib211","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1210\/en.2005-1280","article-title":"Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake","volume":"147","author":"Smith","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib212","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/28.5.7381192","article-title":"Projections from vasopressin, oxytocin, and neurophysin neurons to neural targets in the rat and human","volume":"28","author":"Sofroniew","year":"1980","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2020.108052_bib213","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0898-6568(96)00174-X","article-title":"G proteins and opioid receptor-mediated signalling","volume":"9","author":"Standifer","year":"1997","journal-title":"Cell. Signal."},{"key":"10.1016\/j.neuropharm.2020.108052_bib214","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2012.09.025","article-title":"Neuromodulation by oxytocin and vasopressin","volume":"76","author":"Stoop","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.conb.2014.09.012","article-title":"Neuromodulation by oxytocin and vasopressin in the central nervous system as a basis for their rapid behavioral effects","volume":"29","author":"Stoop","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib216","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-071714-033904","article-title":"New opportunities in vasopressin and oxytocin research: a perspective from the amygdala","volume":"38","author":"Stoop","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib217","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(93)91655-C","article-title":"Opioid actions on neurons of rat lateral amygdala in vitro","volume":"612","author":"Sugita","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib218","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1113\/jphysiol.1993.sp019495","article-title":"Membrane properties and synaptic potentials of three types of neurone in rat lateral amygdala","volume":"460","author":"Sugita","year":"1993","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib219","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib220","doi-asserted-by":"crossref","first-page":"8296501","DOI":"10.1155\/2017\/8296501","article-title":"Amygdala plasticity and pain","volume":"2017","author":"Thompson","year":"2017","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.neuropharm.2020.108052_bib221","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2018.11.037","article-title":"Cortico-limbic pain mechanisms","volume":"702","author":"Thompson","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108052_bib222","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/cne.21884","article-title":"Electron microscopic localization of corticotropin-releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala","volume":"512","author":"Treweek","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib223","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.physbeh.2006.03.012","article-title":"Limbic and HPA axis function in an animal model of chronic neuropathic pain","volume":"88","author":"Ulrich-Lai","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108052_bib224","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108052_bib225","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2826.1998.00254.x","article-title":"Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response","volume":"10","author":"van Bockstaele","year":"1998","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib227","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-7634(96)00023-1","article-title":"Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors","volume":"21","author":"Van Rossum","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.108052_bib228","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neuropharm.2017.08.009","article-title":"CRF modulates glutamate transmission in the central amygdala of naive and ethanol-dependent rats","volume":"125","author":"Varodayan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108052_bib229","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-9861(19970707)383:3<305::AID-CNE3>3.0.CO;2-7","article-title":"Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study","volume":"383","author":"Veinante","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib230","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/00001756-199709080-00035","article-title":"GABA- and peptide-immunoreactivities co-localize in the rat central extended amygdala","volume":"8","author":"Veinante","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.108052_bib231","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9256-1-9","article-title":"The amygdala between sensation and affect: a role in pain","volume":"1","author":"Veinante","year":"2013","journal-title":"J.Mol.Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108052_bib232","article-title":"Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression","volume":"1\u201313","author":"Wegener","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib233","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2019.07.027","article-title":"The negative affect of protracted opioid abstinence: progress and perspectives from rodent models","volume":"87","author":"Welsch","year":"2020","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108052_bib234","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.celrep.2019.09.011","article-title":"Dual and opposing functions of the central amygdala in the modulation of pain","volume":"29","author":"Wilson","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2020.108052_bib235","doi-asserted-by":"crossref","first-page":"14611","DOI":"10.1038\/ncomms14611","article-title":"Endogenous opioids regulate moment-to-moment neuronal communication and excitability","volume":"8","author":"Winters","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.108052_bib236","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0087-19.2019","article-title":"Molecular, morphological, and functional characterization of corticotropin-releasing factor receptor 1-expressing neurons in the central nucleus of the amygdala","volume":"6","author":"Wolfe","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2020.108052_bib237","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0333102417702120","article-title":"Kappa opioid receptor antagonists: a possible new class of therapeutics for migraine prevention","volume":"37","author":"Xie","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.108052_bib238","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0306-4522(03)00069-1","article-title":"Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway","volume":"118","author":"Xu","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib239","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cne.21159","article-title":"Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain","volume":"500","author":"Xu","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","article-title":"Neuropeptide S; A neuropeptide promoting arousal and anxiolytic-like effects","volume":"43","author":"Xu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108052_bib241","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2016.05.005","article-title":"Intra-amygdala microinfusion of neuropeptide S attenuates neuropathic pain and suppresses the response of spinal microglia and astrocytes after spinal nerve ligation in rats","volume":"82","author":"Yang","year":"2016","journal-title":"Peptides"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.108052_bib242","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.j.pain.0000460343.46847.58","article-title":"Role of endogenous pain modulation in chronic pain mechanisms and treatment","volume":"156","author":"Yarnitsky","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2020.108052_bib243","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cne.903080212","article-title":"Calcitonin gene-related peptide (CGRP) immunoreactive projections from the thalamus to the striatum and amygdala in the rat","volume":"308","author":"Yasui","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108052_bib244","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00429-018-01825-1","article-title":"Cell-type specific parallel circuits in the bed nucleus of the stria terminalis and the central nucleus of the amygdala of the mouse","volume":"224","author":"Ye","year":"2019","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108052_bib245","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neuroscience.2015.07.002","article-title":"Mu opioid receptor localization in the basolateral amygdala: an ultrastructural analysis","volume":"303","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib246","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnbeh.2019.00138","article-title":"Neuropeptide S ameliorates cognitive impairment of APP\/PS1 transgenic mice by promoting synaptic plasticity and reducing abeta deposition","volume":"13","author":"Zhao","year":"2019","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108052_bib247","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuroscience.2012.01.022","article-title":"Neuropeptide S promotes wakefulness through activation of the posterior hypothalamic histaminergic and orexinergic neurons","volume":"207","author":"Zhao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib248","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2005.02.004","article-title":"Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons","volume":"133","author":"Zhu","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108052_bib249","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108052_bib250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.neuropharm.2016.03.054","article-title":"Neuropeptide S reduces fear and avoidance of con-specifics induced by social fear conditioning and social defeat, respectively","volume":"108","author":"Zoicas","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:01:00Z","timestamp":1758438060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820301180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":250,"alternative-id":["S0028390820301180"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108052","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amygdala, neuropeptides, and chronic pain-related affective behaviors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108052"}}